NCT04714086 2024-10-24Expanded Access Program for AvapritinibBlueprint Medicines CorporationNo longer available
NCT03862885 2020-07-27Early Access Program (EAP) for Avapritinib in Patients With Locally Advanced Unresectable or Metastatic GISTBlueprint Medicines CorporationApproved for marketing